|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 215/233 | |
| C07D 215/56 | |||
| C07C 229/66 |
| (11) | Number of the document | 3330255 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17193267.6 |
| Date of filing the European patent application | 2010-03-19 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 162148 P | 2009-03-20 | US | |
| 246303 P | 2009-09-28 | US | |
| 248565 P | 2009-10-05 | US |
| (72) |
DEMATTEI, John, US
LOOKER, Adam R., US
NEUBERT-LANGILLE, Bobbianna, US
TRUDEAU, Martin, CA
ROPER, Stefanie, US
RYAN, Michael, US
YAP, Dahrika Milfred Lao, US
KRUEGER, Brian R., US
GROOTENHUIS, Peter D.J., US
VAN GROOR, Frederick F., US
BOTFIELD, Martyn C., US
ZLOKARNIK, Gregor, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |